血液透析患者の透析中の身体的苦痛に関する文献検討...血液透析患者の透析中の保温に関する文献検討 表 透析中の身体症状に対するアプローチ
透析液清浄化ガイドライン Ver. 2.01€析液清浄化ガイドライン Ver. 2.01 2014年...
Transcript of 透析液清浄化ガイドライン Ver. 2.01€析液清浄化ガイドライン Ver. 2.01 2014年...
-
Ver. 2.0
201 3 11
-
1
11 50
22
AB
HDF/HF
HDF/HF
HDF/HF
5121
MF
512
51
AB
HDF/HF
-
2
Reverse Osmosis : RO
5352 TOC
RO
UF
RO
BA
BB
B
A
A
ET Retentive filter(ETRF)
HDF/HF
Annex
-
3
2004 ISO/AAMI
2009ISO 116635
139586)1395972672282011ISO 235009
20101HDF/HF
4
2012403051
HDF2
HDF/HF
ISO
32
17710
-
4
http://www.mhlw.go.jp/topics/bukyoku/kenkou/suido/kijun/kijunc
hi.html
11 50H23.4.1
1 100/mL
2
0.003mg/L
0.0005mg/L
5 0.01mg/L
6 0.01mg/L
7 0.01mg/L
0.05mg/L
9 0.01mg/L
10 10mg/L
11 0.8mg/L
12 1.0mg/L
13 0.002mg/L
14 1,4- 0.05mg/L
15 -1,2--1,2-
214 0.04mg/L
16 0.02mg/L
17 0.01mg/L
18 0.01mg/L
19 0.01mg/L
20 0.6 mg/L
21 0.02mg/L
22 0.06mg/L
http://www.mhlw.go.jp/topics/bukyoku/kenkou/suido/kijun/kijunchi.htmlhttp://www.mhlw.go.jp/topics/bukyoku/kenkou/suido/kijun/kijunchi.html
-
5
23 0.04mg/L
2 0.1mg/L
25 0.01mg/L
26 0.1mg/L
27 0.2mg/L
28 0.03mg/L
29 0.09mg/L
30 0.08mg/L
31 1.0mg/L
32 0.2mg/L
33 0.3mg/L
34 1.0mg/L
35 200mg/L
36 0.05mg/L
37 200mg/L
38 () 300mg/L
39 500mg/L
40 0.2mg/L
41 0.00001mg/L
42 2- 0.00001mg/L
43 0.02mg/L
44 0.005mg/L
45 (TOC) mg/L
46 pH 5.88.6
47
48
49 5
50 2
ISO
139597)ISO 235009)1
-
6
22
No mg/L
1 2 (0.1mEq/L)
2 (0.3mEq/L)
3 8 (0.2mEq/L)
70 (3.0mEq/L)
5 0.006
6 0.005
7 0.10
8 0.000
9 0.001
10 0.01
11 0.005
12 0.0002
13 0.09
1 0.005
15 0.01
16 0.10
1 0.10
1 0.20
2.0
100
0.002
0.10
Annex
-
7
0.0EU/mL 0.001 EU/mL
1 CFU/mL 0.CFU/mL
L100mL
AB
0.00EU/mL
1 CFU/mL 0.CFU/mL
L100mL
2 HDF/HF
0.001EU/mL
1 CFU/mL
L100mL
0.00EU/mL
1 CFU/mL 0.CFU/mL
L100mL
0.001EU/mL
0.1 CFU/L
0L100mL
0.001EU/mL
0.1 CFU/L 1 CFU/L
0L100mL
-
8
HDF/HF
0.001EU/mL
1 CFU/mL
L100mL
HDF/HF
0.001EU/mL
1 CFU/mLnot detected
0L100mL
RO
AB
A 40 B 20
MF
Reasoners Agar No2
20
RA
0.05100L
-
9
5121
512 MF
MF m
11
512
HDF/HF
12)13)
1
RO
RORO
500mL/min
-
10
AB
Annex
500mL/min
500mL/min
2ETRF
HDF/HF
500mL/min
22ETRF
-
11
1
RO
25 m
P
RO)
-
12
CaMgAl Na
Na
NaNa
NaCl
Na
0.1mg/L
FRP
-
13
DPDP
Reverse Osmosis : RO
RO RO
RO
RO
5351
RO 5075
/100
5075
-
14
5352 Total Organic CarbonTOC
RO
TOC
0.5mg/L500ppb
TOC
535
RO
25
535 RO
RO
RO
RO RO
3 RO
RO 56
RO
DNA 260nm
253.7nm
-
15
7,0008,000
RO
A
UF
ROET100ROUF
RO
UF
UF
UF
UFET
ROET
UF
ROUF
3 RO
ROICU
-
16
1/1/
RO
RO
BBA
A
BA
B
AA
B
B
BB
B
ETB
100ppm
B
-
17
B
B
BA
B
A
A
A
ET
A
A
pH
5
-
18
ET Retentive filterETRF
ETETRF
ETRF
ETRF
ETRF
ET
ET
-
19
0.020.1
Na 30 RO
HDF/HF
HDF JIS T
3250 4.5.2 HDF
-
20
1) .
.2004.126-132
2) Clinical Engineering 6
2005 Vol No.5.548-556
1) Henderson LW,Koch KM,Dinarello CA,et all Hemodialysis
hypotensionThe interleukin hypothesis,Blood purification 1: 3-8,
1983
2) VOL.30.NO,1
13-20, 2002
3) VOL.30.NO,7
427-429, 2002
4) Schindler R,Beck W,Deppisch R,et al:Short bacterial DNA
fragments:detection in dialysate and induction of cytokinesJ Am Soc
Nephrol 15(12):3207-3214,2004
5) ISO 11663Quality of dialysis fluid for haemodialysis and related
therapies.
First edition 2009-04-15
6) ISO 13958Concentrates for haemodialysis and related
therapies .Second edition 2009-04-15
7) ISO 13959Water for haemodialysis and related therapies. Second
edition 2009-04-15
8) ISO 26722Water treatment equipment for haemodialysis
applications and related therapies. First edition 2009-04-15
9) ISO 23500Guidance for the preparation and quality management
of fluids for haemodialysis and related therapies. First edition
2011-05-15
10) 101 2005
11)
42(1):85-90,2009
12) 33:
, 2009
13) RO
40(12):1051-1056,2007
-
21
14) 2011 (ETRF)
44(9):977~990,2011
Annex
ISO
1) http://www.iso.org/iso/store.htm
2) http://www.webstore.jsa.or.jp/webstore/ISO/html/jp/menu.htm?lang=jp
3 RO
RO
RO 510
100
4RO
ET
RO 100
0.15ET
O
1 EU ET
ET
5
ET
6
137 134 131
-
22
90%
7
512 MF
L
MF